Clinical trial
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
NCT03257345 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
- Lead sponsor
- University Hospital Southampton NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 3, 2017
- Completion date
- December 31, 2019
- Enrollment
- 360 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, ulcerative colitis